← FDA DRUG APPROVALS

FDA ANDA · ANDA071893

ACETOHEXAMIDE

Sponsor: WATSON LABS TEVA

APPLICATION
ANDA071893
TYPE
ANDA
ORIGINAL APPROVAL
1987-11-25
LATEST ACTION
1996-10-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ACETOHEXAMIDEDiscontinued
ACETOHEXAMIDE 250MG · TABLET · ORAL

Approval history

1996-10-30Manufacturing (CMC) · Supplement 8AP
1991-09-09Labeling · Supplement 7AP
1991-02-27Manufacturing (CMC) · Supplement 6AP
1991-02-27Manufacturing (CMC) · Supplement 2AP
1991-02-27Manufacturing (CMC) · Supplement 3AP
1991-01-28Manufacturing (CMC) · Supplement 5AP
1990-06-29Manufacturing (CMC) · Supplement 1AP
1987-11-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →